Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease

NCT07570836 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease (ILD)

Interventions

BIOLOGICAL: Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles (hUCMSC-EVs)
BIOLOGICAL: Normal Saline Placebo

Sponsor

Shanghai Zhongshan Hospital